NCT06073925View on ClinicalTrials.gov

Use of Vitamin D as An Adjuvant Treatment in Children With Chronic Idiopathic Thrombocytopenic Purpura

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

October 31, 2024

Conditions
Immune Thrombocytopenia
Interventions
DRUG

VIT D

50000 IU per week of VIT D

All Listed Sponsors
lead

Mansoura University

OTHER

NCT06073925 - Use of Vitamin D as An Adjuvant Treatment in Children With Chronic Idiopathic Thrombocytopenic Purpura | Biotech Hunter | Biotech Hunter